549 related articles for article (PubMed ID: 8061026)
21. Prolonged survival of hamster-to-rat pulmonary xenografts by tacrolimus (FK506) and cyclophosphamide.
Komatsu K; Youm W; Konishi H; Kawaharada N; Yousem SA; Murase N; Griffith BP; Pham SM
J Heart Lung Transplant; 1996 Jul; 15(7):722-7. PubMed ID: 8820789
[TBL] [Abstract][Full Text] [Related]
22. The prolongation of concordant hamster-to-rat cardiac xenografts by brequinar sodium.
Cramer DV; Chapman FA; Jaffee BD; Zajac I; Hreha-Eiras G; Yasunaga C; Wu GD; Makowka L
Transplantation; 1992 Sep; 54(3):403-8. PubMed ID: 1412717
[TBL] [Abstract][Full Text] [Related]
23. Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine.
Lin Y; Sobis H; Vandeputte M; Waer M
Transplant Proc; 1994 Dec; 26(6):3202. PubMed ID: 7998115
[No Abstract] [Full Text] [Related]
24. Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone.
Lin Y; Sobis H; Vandeputte M; Waer M
Transplant Proc; 1994 Oct; 26(5):3052. PubMed ID: 7940959
[No Abstract] [Full Text] [Related]
25. Phase-directed therapy and cardiac xenograft survival.
Lin H; Gastman BR; Wei RQ; Kunkel SL; Gordon D; Bolling SF
J Surg Res; 1997 Sep; 72(1):84-8. PubMed ID: 9344718
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection.
Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945
[No Abstract] [Full Text] [Related]
27. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
[No Abstract] [Full Text] [Related]
28. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts.
Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH
J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031
[TBL] [Abstract][Full Text] [Related]
29. A crucial effect of splenectomy on prolonging cardiac xenograft survival in combination with cyclosporine.
Monden M; Valdivia LA; Gotoh M; Kubota N; Hasuike Y; Nakano Y; Okamura J; Mori T
Surgery; 1989 Apr; 105(4):535-42. PubMed ID: 2648630
[TBL] [Abstract][Full Text] [Related]
30. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
[TBL] [Abstract][Full Text] [Related]
31. Histological and immunological characteristics of, and the effect of immunosuppressive treatment on, xenograft vasculopathy.
Briffa NP; Shorthouse R; Chan J; Silva H; Billingham M; Brazelton T; Morris RE
Xenotransplantation; 2004 Mar; 11(2):149-59. PubMed ID: 14962277
[TBL] [Abstract][Full Text] [Related]
32. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948
[No Abstract] [Full Text] [Related]
33. Brequinar and brequinar analogues in rat allo- and xenotransplantation.
Schuurman HJ; Tanner M; Pally C; Jaffee BD
Transplant Proc; 1998 Aug; 30(5):2240-3. PubMed ID: 9723456
[No Abstract] [Full Text] [Related]
34. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model.
Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
Transplantation; 2003 May; 75(9):1475-81. PubMed ID: 12792500
[TBL] [Abstract][Full Text] [Related]
35. Graft adaptation in hamster-to-rat cardiac xenografts.
Hasan RI; Sriwatanawangosa V; Wallwork J; White DJ
Transplant Proc; 1994 Jun; 26(3):1282-3. PubMed ID: 8029909
[No Abstract] [Full Text] [Related]
36. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
Lin Y; Sobis H; Vandeputte M; Waer M
Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
[No Abstract] [Full Text] [Related]
37. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H
Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059
[No Abstract] [Full Text] [Related]
38. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
Chong AS; Shen J; Xiao F; Blinder L; Foster P; Sankary H; Williams JW
Transplant Proc; 1996 Apr; 28(2):684. PubMed ID: 8623344
[No Abstract] [Full Text] [Related]
39. Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.
Cramer DV; Chapman FA; Makowka L
Transplant Proc; 1993 Jun; 25(3 Suppl 2):23-8. PubMed ID: 8516938
[TBL] [Abstract][Full Text] [Related]
40. Leflunomide and cyclosporine immunomodulation in intestinal xenotransplantation.
Foster PF; Kociss K; Shen J; Sankary HN; Xiao F; Williams JW
Transplant Proc; 1996 Oct; 28(5):2527-8. PubMed ID: 8907935
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
